Becton-Dickinson is known for creating the world’s first insulin syringe in 1924, almost immediately after the discovery of insulin. At the moment, Becton-Dickinson is the world leader in the manufacture of insulin injection devices and the latest generation of Micro-Fine Plus products clearly shows why

Among the distinctive features of the latest generation of disposable insulin syringes:

• High accuracy of dosing is ensured by minimizing the problem of the “dead zone” through the integration of a non-removable needle. This also reduces the risk of developing diabetes.
• A special patented silicone coating minimizes tissue injury and reduces the risk of lipohypertrophy.
• The piston is manufactured using the latest latex-free technology, which minimizes the risk of latex allergic reactions in patients and medical staff.
• A large and unwashed scale ensures accurate insulin dosing for patients with low vision.
• BD Micro-Fine Plus® insulin syringes can be distinguished by volume (0.3-0.5-1.0 ml), dosing step (2 – 1 – 0.5 U) and needle length (8 – 12.7 mm), which allows you to choose a syringe with a needle that is ideal for a particular patient.
• BD Micro-Fine Plus® insulin syringes were designed not only for adult patients. The 2 U scale step allows you to easily measure the dose of insulin needed for a child. BD Micro-Fine Plus insulin syringes can be recommended not only for pregnant women, but also for patients who have been prescribed insulin for the first time: a thin and small needle of 0.3 mm x 8 mm will make the injection more painless.

Material of manufacture:

• Piston, cylinder: polypropylene.
• Piston seal: synthetic rubber that does not contain latex.
• Lubricant: silicone oil.